Stay updated on SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The revision label at the bottom updates from Revision: v3.5.2 to Revision: v3.5.3. This indicates a version update in the site's documentation/UI.
    Difference
    0.1%
    Check dated 2026-04-29T10:51:10.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated the page’s revision/version indicator shown at the bottom of the record (v3.5.0 → v3.5.2).
    Difference
    0.1%
    Check dated 2026-04-22T06:19:59.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-24T11:10:45.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. This appears to be a maintenance update affecting the site version only and not the study content.
    Difference
    0.1%
    Check dated 2026-03-10T02:44:42.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Minor site revision updated from v3.4.1 to v3.4.2; no changes to study details or visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-16T16:13:52.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1; removed the funding-status notice and Revision: v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-09T12:26:56.000Z thumbnail image

Stay in the know with updates to SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SB3 vs. Herceptin® in HER2+ Breast Cancer Clinical Trial page.